COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 324: Articles 3231-3240  | Next

Prevalence of Long COVID-associated symptoms in adults with and without SARS-CoV-2 infection in Germany: Results of the population-based study: Corona Monitoring Nationwide 2021/22 (RKI-SOEP-2)
Poethko-Mueller, C., Ordonez-Cruickshank, A., Nuebel, J., Sarganas, G., Goesswald, A., Schmid, L., Schaffrath Rosario, A., Hoebel, J., Schlaud, M., Scheidt-Nave, C.
10.1101/2023.09.12.23295426 — Posted: 2023-09-12
Excess risk of Covid-19 infection and mental distress in healthcare workers during successive pandemic waves. Analysis of matched cohorts of healthcare workers and community referents in Alberta, Canada
Galarneau, J.-M., Labreche, F., Durand-Moreau, Q., Ruzycki, S., Adisesh, A., Burstyn, I., Zadunayski, T., Cherry, N.
10.1101/2023.09.12.23295439 — Posted: 2023-09-12
Digital holo-tomographic 3D maps of COVID-19 microclots in blood to assess disease severity
Bergaglio, T., Synhaivska, O., Nirmalraj, P.
10.1101/2023.09.12.557318 — Posted: 2023-09-12
Examining Functional Linkages Between Conformational Dynamics, Protein Stability and Evolution of Cryptic Binding Pockets in the SARS-CoV-2 Omicron Spike Complexes with the ACE2 Host Receptor: Recombinant Omicron Variants Mediate Variability of Conserved Allosteric Sites and Binding Epitopes
Alshahrani, M., Gupta, G., Xiao, S., Tao, P., Verkhivker, G.
10.1101/2023.09.11.557205 — Posted: 2023-09-12
WELPCR: Low-cost polymerase chain reaction (PCR) thermal cycler for nucleic acid amplification and sensing
Mandal, P., Dhakane, V., Kulkarni, A., Tallur, S.
10.1101/2023.09.11.557292 — Posted: 2023-09-12
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
Qu, P., Xu, K., Faraone, J. N., Goodarzi, N., Zheng, Y.-M., Carlin, C., Bednash, J. S., Horowitz, J. C., Mallampalli, R. K., Saif, L. J., Oltz, E. M., Jones, D., Gumina, R. J., Liu, S.-L.
10.1101/2023.09.11.557206 — Posted: 2023-09-12
Compartmentalized SARS-CoV-2 replication in upper versus lower respiratory tract after intranasal inoculation or aerosol exposure
Fischer, R., Bushmaker, T., Williamson, B. N., Perez-Perez, L., Feldmann, F., Lovaglio, J., Scott, D., Saturday, G., Feldmann, H., Munster, V. J., de Wit, E., van Doremalen, N.
10.1101/2023.09.11.557190 — Posted: 2023-09-12
Dual inhibition of coronavirus Mpro and PLpro enzymes by phenothiazines and their antiviral activity
Forrestall, K. L., Pringle, E. S., Sands, D., Duguay, B., Farewell, B., Woldemariam, T., Falzarano, D., Pottie, I. R., McCormick, C., Darvesh, S.
10.1101/2023.09.11.557219 — Posted: 2023-09-12
Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses
Barouch, S. E., Chicz, T. M., Blanc, R., Barbati, D. R., Parker, L. J., Tong, X., McNamara, R. P.
10.1101/2023.09.12.557347 — Posted: 2023-09-12
Comparative Analysis of Association Networks Using Single-Cell RNA Sequencing Data Reveals Perturbation-Relevant Gene Signatures
Nouri, N., Gaglia, G., Mattoo, H., de Rinaldis, E., Savova, V.
10.1101/2023.09.11.556872 — Posted: 2023-09-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).